281 related articles for article (PubMed ID: 17162000)
1. Impact of tumor size on the predictive ability of the pT3a primary tumor classification for renal cell carcinoma.
Siddiqui SA; Frank I; Leibovich BC; Cheville JC; Lohse CM; Zincke H; Blute ML
J Urol; 2007 Jan; 177(1):59-62. PubMed ID: 17162000
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
Yoo C; Song C; Hong JH; Kim CS; Ahn H
J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
[TBL] [Abstract][Full Text] [Related]
3. Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort.
Frank I; Blute ML; Leibovich BC; Cheville JC; Lohse CM; Zincke H
J Urol; 2005 Jun; 173(6):1889-92. PubMed ID: 15879769
[TBL] [Abstract][Full Text] [Related]
4. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
J Urol; 2007 Nov; 178(5):1878-82. PubMed ID: 17868733
[TBL] [Abstract][Full Text] [Related]
5. Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved?
Leibovich BC; Cheville JC; Lohse CM; Zincke H; Kwon ED; Frank I; Thompson RH; Blute ML
J Urol; 2005 Mar; 173(3):716-9. PubMed ID: 15711250
[TBL] [Abstract][Full Text] [Related]
6. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
[TBL] [Abstract][Full Text] [Related]
7. Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: progression and long-term survival.
Carini M; Minervini A; Lapini A; Masieri L; Serni S
J Urol; 2006 Jun; 175(6):2022-6; discussion 2026. PubMed ID: 16697790
[TBL] [Abstract][Full Text] [Related]
8. pT1 substaging in renal cell carcinoma: validation of the 2002 TNM staging modification of malignant renal epithelial tumors.
Salama ME; Guru K; Stricker H; Peterson E; Peabody J; Menon M; Amin MB; De Peralta-Venturina M
J Urol; 2005 May; 173(5):1492-5. PubMed ID: 15821466
[TBL] [Abstract][Full Text] [Related]
9. Current TNM classification of renal cell carcinoma evaluated: revising stage T3a.
Siemer S; Lehmann J; Loch A; Becker F; Stein U; Schneider G; Ziegler M; Stöckle M
J Urol; 2005 Jan; 173(1):33-7. PubMed ID: 15592020
[TBL] [Abstract][Full Text] [Related]
10. pT2 classification for renal cell carcinoma. Can its accuracy be improved?
Frank I; Blute ML; Leibovich BC; Cheville JC; Lohse CM; Kwon ED; Zincke H
J Urol; 2005 Feb; 173(2):380-4. PubMed ID: 15643175
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience.
Klatte T; Patard JJ; Goel RH; Kleid MD; Guille F; Lobel B; Abbou CC; De La Taille A; Tostain J; Cindolo L; Altieri V; Ficarra V; Artibani W; Prayer-Galetti T; Allhoff EP; Schips L; Zigeuner R; Figlin RA; Kabbinavar FF; Pantuck AJ; Belldegrun AS; Lam JS
J Urol; 2007 Jul; 178(1):35-40; discussion 40. PubMed ID: 17521678
[TBL] [Abstract][Full Text] [Related]
12. Reassessment of the 1997 TNM classification system for renal cell carcinoma.
Elmore JM; Kadesky KT; Koeneman KS; Sagalowsky AI
Cancer; 2003 Dec; 98(11):2329-34. PubMed ID: 14635066
[TBL] [Abstract][Full Text] [Related]
13. Application of TNM, 2002 version, in localized renal cell carcinoma: is it able to predict different cancer-specific survival probability?
Ficarra V; Novara G; Galfano A; Novella G; Schiavone D; Artibani W
Urology; 2004 Jun; 63(6):1050-4. PubMed ID: 15183948
[TBL] [Abstract][Full Text] [Related]
14. Reclassification of the current tumor, node, metastasis staging in pT3 renal cell carcinoma.
Fujita T; Iwamura M; Yanagisawa N; Muramoto M; Okayasu I; Baba S
Int J Urol; 2008 Jul; 15(7):582-6. PubMed ID: 18479355
[TBL] [Abstract][Full Text] [Related]
15. Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a?
Thompson RH; Leibovich BC; Cheville JC; Lohse CM; Frank I; Kwon ED; Zincke H; Blute ML
J Urol; 2005 Mar; 173(3):918-21. PubMed ID: 15711327
[TBL] [Abstract][Full Text] [Related]
16. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases.
Amin MB; Paner GP; Alvarado-Cabrero I; Young AN; Stricker HJ; Lyles RH; Moch H
Am J Surg Pathol; 2008 Dec; 32(12):1822-34. PubMed ID: 18813125
[TBL] [Abstract][Full Text] [Related]
17. Prognostic stratification of localized renal cell carcinoma by tumor size.
Bedke J; Pritsch M; Buse S; Jakobi H; Elsaesser KH; Pahernik S; Haferkamp A; Hohenfellner M
J Urol; 2008 Jul; 180(1):62-7. PubMed ID: 18485376
[TBL] [Abstract][Full Text] [Related]
18. Proposal of an improved prognostic classification for pT3 renal cell carcinoma.
Terrone C; Gontero P; Volpe A; Porpiglia F; Bollito E; Zattoni F; Frea B; Tizzani A; Fontana D; Scarpa RM; Rossetti SR
J Urol; 2008 Jul; 180(1):72-8. PubMed ID: 18485380
[TBL] [Abstract][Full Text] [Related]
19. Reevaluation of renal cell carcinoma and perirenal fat invasion only.
Jeon HG; Jeong IG; Kwak C; Kim HH; Lee SE; Lee E
J Urol; 2009 Nov; 182(5):2137-43. PubMed ID: 19758661
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]